Exclusive: EU antitrust regulators to okay Siemens Healthineers' $16.4 billion Varian buy - sources
- U.S. stocks close down on news of Biden tax proposal
- Biden To Propose Capital Gains Tax As High As 43.4% For Wealthy - Bloomberg
- Intel (INTC) Tops Q1 EPS by 24c, Offers Guidance
- Snap (SNAP) Tops Q1 EPS by 5c, DAUs were 280 million, Offers Guidance
FILE PHOTO: Siemens Healthineers logo is seen on an item of clothing in manufacturing plant in Forchheim near Nuremberg, Germany, October 7, 2016. REUTERS/Michaela Rehle/File Photo
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
BRUSSELS/MUNICH (Reuters) - EU antitrust regulators are set to grant conditional clearance to German health group Siemens Healthineers' $16.4-billion bid for U.S. peer Varian Medical Systems Inc, three people familiar with the matter said.
The EU green light will come after Siemens Healthineers last month offered concessions to address competition concerns about interoperability, the sources said. Such a measure enables computer systems and software to work with each other.
(Reporting by Foo Yun Chee in Brussels and Alexander Huebner in Munich)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canada's Ontario grapples with third wave, blame piled on its premier
- Biden set to nominate Homendy to head U.S. NTSB
- Technology, high-growth stocks could lose out from Biden's capital gains tax plan